rs72664209

Variant summary

Our verdict is Pathogenic. Variant got 20 ACMG points: 20P and 0B. PVS1PP3_StrongPP5_Very_Strong

The NM_001171.6(ABCC6):​c.2787+1G>T variant causes a splice donor change. The variant allele was found at a frequency of 0.000317 in 1,613,630 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).

Frequency

Genomes: 𝑓 0.00016 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00033 ( 0 hom. )

Consequence

ABCC6
NM_001171.6 splice_donor

Scores

2
4
1
Splicing: ADA: 1.000
2

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:14

Conservation

PhyloP100: 3.69
Variant links:
Genes affected
ABCC6 (HGNC:57): (ATP binding cassette subfamily C member 6) The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 20 ACMG points.

PVS1
Splicing +-2 bp (donor or acceptor) variant, LoF is a know mechanism of disease, No cryptic splice site detected. Exon removal results in frameshift change.
PP3
Splicing scoreres supports a deletorius effect: Scorers claiming Pathogenic: dbscSNV1_ADA, dbscSNV1_RF, max_spliceai. No scorers claiming Uncertain. No scorers claiming Benign.
PP5
Variant 16-16173283-C-A is Pathogenic according to our data. Variant chr16-16173283-C-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 6560.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-16173283-C-A is described in Lovd as [Pathogenic]. Variant chr16-16173283-C-A is described in Lovd as [Likely_pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ABCC6NM_001171.6 linkuse as main transcriptc.2787+1G>T splice_donor_variant ENST00000205557.12
ABCC6NM_001351800.1 linkuse as main transcriptc.2445+1G>T splice_donor_variant
ABCC6NR_147784.1 linkuse as main transcriptn.2649+1G>T splice_donor_variant, non_coding_transcript_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ABCC6ENST00000205557.12 linkuse as main transcriptc.2787+1G>T splice_donor_variant 1 NM_001171.6 P1O95255-1
ABCC6ENST00000576683.1 linkuse as main transcriptn.275G>T non_coding_transcript_exon_variant 3/33
ABCC6ENST00000456970.6 linkuse as main transcriptc.2612+1G>T splice_donor_variant, NMD_transcript_variant 2 O95255-3
ABCC6ENST00000622290.5 linkuse as main transcriptc.2787+1G>T splice_donor_variant, NMD_transcript_variant 5

Frequencies

GnomAD3 genomes
AF:
0.000164
AC:
25
AN:
151994
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00329
Gnomad AMR
AF:
0.0000657
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000309
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000124
AC:
31
AN:
250980
Hom.:
0
AF XY:
0.000118
AC XY:
16
AN XY:
135778
show subpopulations
Gnomad AFR exome
AF:
0.0000616
Gnomad AMR exome
AF:
0.0000289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000256
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000333
AC:
486
AN:
1461636
Hom.:
0
Cov.:
35
AF XY:
0.000326
AC XY:
237
AN XY:
727086
show subpopulations
Gnomad4 AFR exome
AF:
0.0000598
Gnomad4 AMR exome
AF:
0.0000224
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.0000187
Gnomad4 NFE exome
AF:
0.000432
Gnomad4 OTH exome
AF:
0.0000331
GnomAD4 genome
AF:
0.000164
AC:
25
AN:
151994
Hom.:
0
Cov.:
31
AF XY:
0.000108
AC XY:
8
AN XY:
74222
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.0000657
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000309
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000247
Hom.:
0
Bravo
AF:
0.000166
ExAC
AF:
0.0000988
AC:
12
EpiCase
AF:
0.000218
EpiControl
AF:
0.000178

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:14
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Pathogenic:8
Pathogenic, criteria provided, single submitterclinical testingGeneDxAug 29, 2023Observed in patients with pseudoxanthoma elasticum in published literature (Le Saux et al., 2000; Plomp et al., 2008; Pfendner et al., 2008); Canonical splice site variant in a gene for which loss-of-function is a known mechanism of disease; functional studies show variant leads to a new splice site and aberrant splicing, which causes a frameshift and results in an abnormal and truncated protein (Nitschke et al., 2012); This variant is associated with the following publications: (PMID: 16835894, 16086317, 11427982, 24008425, 25525159, 10835643, 21167005, 20189652, 22209248, 29800625, 30215852, 28102862, 15723264, 18253096, 17617515, 33352936, 34205333, 32489700, 10835642, 31589614, 33820832, 35261845, 34925949, 34906475) -
Pathogenic, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, Amsterdam University Medical Center-- -
Pathogenic, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Pathogenic, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenMay 01, 2024ABCC6: PM3:Very Strong, PVS1, PM2 -
Pathogenic, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Pathogenic, criteria provided, single submitterclinical testingRevvity Omics, RevvityJan 11, 2024- -
Pathogenic, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Pathogenic, criteria provided, single submitterclinical testingInvitaeJan 25, 2024This sequence change affects a donor splice site in intron 21 of the ABCC6 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in ABCC6 are known to be pathogenic (PMID: 11536079, 17617515). This variant is present in population databases (rs72664209, gnomAD 0.02%). Disruption of this splice site has been observed in individuals with pseudoxanthoma elasticum or generalized arterial calcification of infancy (PMID: 10835642, 16835894, 18253096, 22209248, 24008425, 25265166). This variant is also known as IVS21+1G>T. ClinVar contains an entry for this variant (Variation ID: 6560). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
Autosomal recessive inherited pseudoxanthoma elasticum Pathogenic:2
Pathogenic, no assertion criteria providedliterature onlyOMIMJan 13, 2012- -
Pathogenic, no assertion criteria providedresearchPXE International-- -
Arterial calcification, generalized, of infancy, 2 Pathogenic:2
Pathogenic, no assertion criteria providedliterature onlyOMIMJan 13, 2012- -
Pathogenic, criteria provided, single submitterclinical testingBaylor GeneticsJun 30, 2023- -
ABCC6-related disorder Pathogenic:1
Likely pathogenic, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesJun 21, 2023The ABCC6 c.2787+1G>T variant is predicted to disrupt the GT donor site and interfere with normal splicing. This variant was reported in patients with pseudoxanthoma elasticum (reported as IVS21+1G>T in Le Saux et al. 2000. PubMed ID: 10835642; Nitschke et al. 2012. PubMed ID: 22209248; reported in compound heterozygous state in Li et al. 2014. PubMed ID: 24008425; Kranenburg et al. 2018. PubMed ID: 29800625). This variant is reported in 0.023% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/16-16267140-C-A). Variants that disrupt the consensus splice donor site in ABCC6 are expected to be pathogenic. This variant is interpreted as likely pathogenic. -
Autosomal recessive inherited pseudoxanthoma elasticum;C1867450:Pseudoxanthoma elasticum, forme fruste;C3276161:Arterial calcification, generalized, of infancy, 2 Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsOct 31, 2018- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.42
D
BayesDel_noAF
Uncertain
-0.010
CADD
Pathogenic
35
DANN
Uncertain
0.99
Eigen
Pathogenic
0.82
Eigen_PC
Uncertain
0.59
FATHMM_MKL
Uncertain
0.94
D
MutationTaster
Benign
1.0
A
GERP RS
4.5

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
1.0
dbscSNV1_RF
Pathogenic
0.75
SpliceAI score (max)
0.99
Details are displayed if max score is > 0.2
DS_DG_spliceai
0.98
Position offset: 2
DS_DL_spliceai
0.99
Position offset: 1

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs72664209; hg19: chr16-16267140; API